Search results
Prescriptions for weight loss, diabetes drugs for young people leaped 600% since 2020, study says
CNN.com· 2 days agoThe number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic...
Column: Expand preventative services to reduce diabetes cases
The Virginian-Pilot· 4 days agoIt is no secret that Type 2 diabetes (T2D) is one of the most common chronic diseases in the United...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Reuters· 24 hours agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
Experts demand obesity action to cure sick note Britain after diabetes surge
Daily Express· 4 days agoExperts are demanding a “tough love” crackdown on obesity to cure sick note Britain after a report...
US FDA panel votes against use of Novo Nordisk’s weekly insulin in type 1 diabetes patients
WHTC 1450 Holland· 24 hours ago(Reuters) - A panel of independent experts to the U.S. health regulator on Friday voted against the...
Hemorrhagic Stroke: How to Spot and Prevent It
Verywell Health via Yahoo News· 7 hours agoStroke risk factors include: Smoking Untreated hypertension Uncontrolled diabetes Heart disease, including atrial fibrillation High low-density...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients By Reuters
Investing.com· 1 day agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an...
Skyrocketing diabetes medication costs force life-and-death decisions for patients
FOX 5 Atlanta· 2 days agoPrices for critical medication are on the rise. ATLANTA - The cost of diabetes medications is on the...
Tandem Diabetes Care (NASDAQ:TNDM) Given New $55.00 Price Target at Stifel Nicolaus
ETF DAILY NEWS· 3 days agoTandem Diabetes Care (NASDAQ:TNDM – Free Report) had its price objective boosted by Stifel Nicolaus from $45.00 to $55.00 in a research note published on Wednesday morning ...
2 Biotech Stocks to Buy in May
Motley Fool via Yahoo Finance· 7 hours agoIt will provide a solid foundation for the company well beyond that time, especially when we consider Vertex's programs in early-stage trials. That...
